查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386274

自體幹細胞和非幹細胞療法市場報告：2030 年趨勢、預測和競爭分析

Autologous Stem Cell and Non-Stem Cell Based Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

自體幹細胞和非幹細胞治療趨勢和預測

至2030年，全球自體幹細胞和非幹細胞治療市場預計將達到130億美元，2024年至2030年的年複合成長率為10.2%。該市場的主要驅動力是對微創治療的需求不斷成長、幹細胞和非幹細胞治療方法的快速技術進步以及政府對促進再生醫學應用的支持不斷增加。全球自體幹細胞和非幹細胞治療市場的未來前景廣闊，醫院和門診手術中心市場充滿機會。

自體幹細胞與非幹細胞治療市場洞察

Lucintel 預測，由於癌症盛行率和治療方法的擴大，以及自體幹細胞治療的使用不斷增加，癌症和腫瘤學預計將在預測期內實現最高成長。

由於慢性病的高盛行率、對微創治療的巨大需求以及有利的政府報銷政策的存在，預計北美在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球自體幹細胞與非幹細胞治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球自體幹細胞和非幹細胞治療市場趨勢（2018-2023）和預測（2024-2030）
  • 按產品類型分類的全球自體幹細胞和非幹細胞療法市場
    • 血壓監測裝置
    • 肺壓監測裝置
    • 顱內壓監測裝置
  • 按類型分類的全球自體幹細胞和非幹細胞治療市場
    • 自體幹細胞
    • 自體非幹細胞
  • 全球自體幹細胞和非幹細胞療法市場（按應用）
    • 神經退化性疾病
    • 自體免疫疾病
    • 癌症和腫瘤
    • 心血管疾病
  • 按最終用途分類的全球自體幹細胞和非幹細胞治療市場
    • 醫院
    • 門診手術中心
    • 其他

第4章 2018-2030年分地區市場趨勢及預測分析

  • 全球自體幹細胞和非幹細胞療法市場（按地區）
  • 北美自體幹細胞與非幹細胞治療市場
  • 歐洲自體幹細胞與非幹細胞治療市場
  • 亞太地區自體幹細胞與非幹細胞治療市場
  • 其他區域自體幹細胞和非幹細胞治療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球自體幹細胞和非幹細胞療法市場成長機會（按產品類型）
    • 全球自體幹細胞和非幹細胞治療市場成長機會（按類型）
    • 全球自體幹細胞和非幹細胞療法市場成長機會（按應用）
    • 全球自體幹細胞和非幹細胞療法市場的成長機會（以最終用途）
    • 全球自體幹細胞和非幹細胞療法市場成長機會（按地區）
  • 全球自體幹細胞和非幹細胞治療市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球自體幹細胞和非幹細胞療法市場的產能
    • 全球自體幹細胞和非幹細胞治療市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • BrainStorm Cell
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • Novartis
  • US Stem Cell
簡介目錄

Autologous Stem Cell and Non-Stem Cell Based Therapy Trends and Forecast

The future of the global autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets. The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.

A more than 150-page report is developed to help in your business decisions.

Autologous Stem Cell and Non-Stem Cell Based Therapy by Segment

The study includes a forecast for the global autologous stem cell and non-stem cell based therapy by product type, type, application, end use, and region.

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Blood Pressure Monitoring Devices
  • Pulmonary Pressure Monitoring Devices
  • Intracranial Pressure Monitoring Devices

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Autologous Stem Cells
  • Autologous Non-Stem Cells

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Neurodegenerative Disorders
  • Autoimmune Diseases
  • Cancer & Tumors
  • Cardiovascular Diseases

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Autologous Stem Cell and Non-Stem Cell Based Therapy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies autologous stem cell and non-stem cell based therapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the autologous stem cell and non-stem cell based therapy companies profiled in this report include-

  • BrainStorm Cell
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • Novartis
  • U.S. Stem Cell

Autologous Stem Cell and Non-Stem Cell Based Therapy Market Insights

Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.

North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.

Features of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market

Market Size Estimates: Autologous stem cell and non-stem cell based therapy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Autologous stem cell and non-stem cell based therapy market size by various segments, such as by product type, type, application, end use, and region in terms of ($B).

Regional Analysis: Autologous stem cell and non-stem cell based therapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, types, applications, end uses, and regions for the autologous stem cell and non-stem cell based therapy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the autologous stem cell and non-stem cell based therapy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the autologous stem cell and non-stem cell based therapy market size?

Answer: The global autologous stem cell and non-stem cell based therapy market is expected to reach an estimated $13.0 billion by 2030.

Q.2 What is the growth forecast for autologous stem cell and non-stem cell based therapy market?

Answer: The global autologous stem cell and non-stem cell based therapy market is expected to grow with a CAGR of 10.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the autologous stem cell and non-stem cell based therapy market?

Answer: The major drivers for this market are growing demand for minimally invasive procedures, rapid technological advancements in stem cell and non-stem cell-based therapies, and rising supportive government initiatives to promote the use of regenerative medicine.

Q4. What are the major segments for autologous stem cell and non-stem cell based therapy market?

Answer: The future of the autologous stem cell and non-stem cell based therapy market looks promising with opportunities in the hospital and ambulatory surgical center markets.

Q5. Who are the key autologous stem cell and non-stem cell based therapy market companies?

Answer: Some of the key autologous stem cell and non-stem cell based therapy companies are as follows:

  • BrainStorm Cell
  • Cytori Therapeutics
  • Dendreon Pharmaceuticals
  • Novartis
  • U.S. Stem Cell

Q6. Which autologous stem cell and non-stem cell based therapy market segment will be the largest in future?

Answer: Lucintel forecasts that cancer & tumor is expected to witness highest growth over the forecast period due to the rising use of autologous therapy along with the expanding incidence of cancer cases and treatments.

Q7. In autologous stem cell and non-stem cell based therapy market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast perioddue to the high prevalence of chronic diseases, existence of significant demand for minimally invasive procedures, and availability of favorable government reimbursement policies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the autologous stem cell and non-stem cell based therapy market by product type (blood pressure monitoring devices, pulmonary pressure monitoring devices, and intracranial pressure monitoring devices), type (autologous stem cells and autologous non-stem cells), application (neurodegenerative disorders, autoimmune diseases, cancer & tumors, and cardiovascular diseases), end use (hospitals, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type
    • 3.3.1: Blood Pressure Monitoring Devices
    • 3.3.2: Pulmonary Pressure Monitoring Devices
    • 3.3.3: Intracranial Pressure Monitoring Devices
  • 3.4: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type
    • 3.4.1: Autologous Stem Cells
    • 3.4.2: Autologous Non-Stem Cells
  • 3.5: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application
    • 3.5.1: Neurodegenerative Disorders
    • 3.5.2: Autoimmune Diseases
    • 3.5.3: Cancer & Tumors
    • 3.5.4: Cardiovascular Diseases
  • 3.6: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region
  • 4.2: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.2.1: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.2.2: North American Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.3: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.3.1: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.3.2: European Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.4.1: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.4.2: APAC Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 4.5.1: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application: Neurodegenerative Disorders, Autoimmune Diseases, Cancer & Tumors, and Cardiovascular Diseases
    • 4.5.2: ROW Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use: Hospitals, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Type
    • 6.1.3: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Application
    • 6.1.4: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by End Use
    • 6.1.5: Growth Opportunities for the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market by Region
  • 6.2: Emerging Trends in the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Autologous Stem Cell and Non-Stem Cell Based Therapy Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: BrainStorm Cell
  • 7.2: Cytori Therapeutics
  • 7.3: Dendreon Pharmaceuticals
  • 7.4: Novartis
  • 7.5: U.S. Stem Cell